Online citations, reference lists, and bibliographies.

Is Drug Consumption Correlated With Benign Paroxysmal Positional Vertigo (BPPV) Recurrence?

P. Picciotti, T. Di Cesare, Laura Tricarico, E. De Corso, J. Galli, G. Paludetti
Published 2020 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Background Benign paroxysmal positional vertigo (BPPV) is the most common cause of peripheral vertigo and its recurrence is fairly common. Several studies correlated the pathophysiological role of different comorbidities—such as diabetes, osteoporosis, vascular, psychiatric and autoimmune diseases—in the development and recurrence of BPPV. The aim of this study is to analyse the pharmacological history of patients with idiopathic BPPV in relation to the risk of developing recurrence. Methods Data regarding 715 patients aged 12 to 87 years (62.7 ± 14) with non-traumatic BPPV were retrospectively evaluated. These refer to the Vestibular Service, day clinic, and were collected over a 4-year period, between 2014 and 2018. Results Recurrence of BPPV was observed in 220/715 patients (30.76%). A statistically significant correlation ( p  < 0.006) between recurrence and drug consumption was observed for SNC agents ( p  = 0.0001), vitamin D ( p  = 0.0005), PPI ( p  = 0.0007), thyroid hormones ( p  = 0.0011), and antihypertensives in single use ( p  = 0.0031). On the contrary, cholesterol-lowering statin drugs, hypoglycaemic agents, antiplatelet medication, estroprogestins and combination of two or more antihypertensives did not show significant correlation. Conclusion Specific classes of drugs are significantly associated with recurrence: antihypertensive therapy with a singular agent, central nervous system agents, PPIs, vitamin D and thyroid hormones. On the other hand, the lack of correlation between some drugs and recurrence could be linked to the effectiveness of therapy in controlling hypertension, dyslipidaemia and diabetes. Pharmacological history is an essential tool to identify patients at risk of BPPV recurrence.
This paper references
10.1212/01.wnl.0000345016.33983.e0
Osteopenia and osteoporosis in idiopathic benign positional vertigo
S. Jeong (2009)
10.3109/14992027.2016.1143981
Comorbidities and recurrence of benign paroxysmal positional vertigo: personal experience
P M Picciotti (2016)
10.1080/00016480500280140
Benign paroxysmal positioning vertigo: A long-term follow-up (6–17 years) of 125 patients
T. Brandt (2006)
10.1186/1471-2377-7-29
Supported treadmill training to establish walking in non-ambulatory patients early after stroke
L. Ada (2007)
10.7326/0003-4819-66-5-917
The absorption of calcium carbonate.
P. Ivanovich (1967)
10.1007/s00415-008-0697-x
Psychiatric comorbidity in different organic vertigo syndromes
A. Eckhardt-Henn (2008)
10.1016/j.otohns.2010.06.905
Benign paroxysmal positional vertigo secondary to inner ear disease
No-Hee Lee (2010)
10.1111/J.1749-6632.2001.TB03737.X
Exercise and drug therapy alter recovery from labyrinth lesion in humans.
M. Strupp (2001)
[Anxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo].
Hahn Jin Jung (2013)
10.1097/GME.0000000000000190
Menopause and benign paroxysmal positional vertigo
O. A. Ogun (2014)
10.3109/00016482009123103
Diagnose yon Krankheitserscheinungen im Bereiche des Otolithenapparates
E. Barany (1920)
10.1177/000348940611500804
Prospective Study of Positional Nystagmus in 100 Consecutive Patients
P. Bertholon (2006)
10.1097/01.MLG.0000154723.55044.B5
Effectiveness of treatment techniques in 923 cases of benign paroxysmal positional vertigo.
R. L. Steenerson (2005)
10.1097/TA.0b013e3181d0c3d9
Clinical characteristics and treatment of benign paroxysmal positional vertigo after traumatic brain injury.
Seong-Ki Ahn (2011)
10.1186/1471-2377-9-29
Co-morbidities of vertiginous diseases
Jan C Warninghoff (2009)
10.1007/978-3-642-36485-3_4
Benign Paroxysmal Positional Vertigo (BPPV)
Shabih H. Zaidi (2013)
10.1042/cs0870567
Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects.
A. Pellacani (1994)
10.1007/s00405-014-3175-3
Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo
H. Talaat (2014)
10.1016/j.heares.2011.08.006
Physiopathology of the cochlear microcirculation
X. Shi (2011)
Benign paroxysmal positional vertigo (BPPV). Treasure Island (FL): StatPearls Publishing
R Palmeri (2019)
10.1136/bmj.307.6918.1507
Benign paroxysmal positional vertigo.
S. Denholm (1993)
10.1016/j.psym.2013.02.005
Vertigo "in the pink": The impact of female gender on psychiatric-psychosomatic comorbidity in benign paroxysmal positional vertigo patients.
S. Ferrari (2014)
10.1016/j.anl.2013.07.007
A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo.
A. De Stefano (2014)
10.1016/0016-5085(90)90946-X
Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis.
J. B. Jansen (1990)
10.1054/MEHY.1999.0905
A relationship between autoimmune thyroiditis and benign paroxysmal positional vertigo?
G. Modugno (2000)
The B1 receptors for kinins.
F. Marceau (1998)
10.1056/NEJMcp1309481
Clinical practice. Benign paroxysmal positional vertigo.
Ji-soo Kim (2014)
10.1016/J.AMJMED.2005.02.007
Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.
M. B. O'Connell (2005)
10.1136/jnnp.2003.031500
Benign paroxysmal positional vertigo predominantly affects the right labyrinth
M. von Brevern (2004)
10.1016/j.amjoto.2010.07.009
Benign paroxysmal positional vertigo following whiplash injury: a myth or a reality?
Francesco Dispenza (2011)
Cupulolithiasis
HF Schuknecht (1969)
10.1097/MAO.0b013e31818f5777
Relationship Between Bone Mineral Density and Clinical Features in Women With Idiopathic Benign Paroxysmal Positional Vertigo
Yoon Seok Jang (2009)
Diagnose von krankheitserscheinungen im. Bereiche des otolithenapparates [in German
R Barany (1921)
10.1136/jnnp.60.1.68
Benign paroxysmal positional vertigo of the horizontal canal.
G. De la Meilleure (1996)
10.1177/0194599812454642
Clinical Features of Recurrent or Persistent Benign Paroxysmal Positional Vertigo
S. J. Choi (2012)
10.1288/00005537-199209000-00006
Free-floating endolymph particles: a new operative finding during posterior semicircular canal occlusion.
L. Parnes (1992)
10.1136/JNNP.2003.031500
Benign paroxysmal positional vertigo (BPPV) predominantly affects the right labyrinth
W. Damman (2004)
10.1177/0194599811407610
Association between Type 1 Diabetes Mellitus and Deposits in the Semicircular Canals
S. Yoda (2011)
10.1016/j.anl.2015.08.009
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.
H. Talaat (2016)
Paroxysmal positional vertigo: the role of age as a prognostic factor.
M. Faralli (2006)
Diagnose von krankheitserscheinungen im
R Barany (1921)
10.3233/VES-1998-8404
Why do benign paroxysmal positional vertigo episodes recover spontaneously?
G. Zucca (1998)
10.1080/00016489.2016.1247986
The evaluation of anxiety and panic agarophobia scores in patients with benign paroxysmal positional vertigo on initial presentation and at the follow-up visit
Serif Samil Kahraman (2017)
10.14639/0392-100X-1121
Italian survey on benign paroxysmal positional vertigo
Adriana Messina (2017)
10.3346/jkms.2006.21.3.539
Clinical Characteristics of Benign Paroxysmal Positional Vertigo in Korea: A Multicenter Study
S. Moon (2006)
10.1016/S0140-6736(97)02342-8
Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
R. Lindsay (1997)



Semantic Scholar Logo Some data provided by SemanticScholar